Regulon

Regulon: R-2099

Regulons are regulatory units consisting of a coherently expressed set of genes and the associated regulator(s) whose binding site(s) they share.

Regulon Summary

Regulon summary table displays all associated information related to the specific regulon including the number of genes in the regulon, Hazard ratio, its Regulator, the Transcriptional Program that includes the regulon, Drugs that are associated with members of the regulon, together with mechanism of action and class, and enriched hallmarks of cancer if any.

GenesCox Hazard RatioRegulatorsCausal FlowsTranscriptional ProgramsHallmarks
142.1239410Pr-14Self sufficiency in growth signalInsensitivity to antigrowth signalEvading apoptosisSustained angiogenesisTissue invasion and metastasisTumor-promoting inflammationReprogramming energy metabolismEvading immune detectionLimitless replicative potentialGenome instability and mutation

Regulon Genes

List of genes that are included in the regulon. These genes have similar expression profiles in subset of patients and they share common binding motif for the Regulator of the regulon. Clicking on the gene name will take you to the gene specific page with more details. Please wait while information is collated from several resources after you click.

Entrez IDEnsEMBL IDPreferred NameUniprot ID
23161 ENSG00000071189 SNX13 A0A087WUZ7
334 ENSG00000084234 APLP2 Q06481
3717 ENSG00000096968 JAK2 O60674
5216 ENSG00000108518 PFN1 P07737
50862 ENSG00000110315 RNF141 Q8WVD5
10114 ENSG00000110422 HIPK3 Q9H422
6272 ENSG00000134243 SORT1 Q99523
79634 ENSG00000144306 SCRN3 Q0VDG4
9180 ENSG00000145623 OSMR Q99650
6565 ENSG00000163406 SLC15A2 Q16348
4973 ENSG00000173391 OLR1 A0A024RAU0
3766 ENSG00000177807 KCNJ10 P78508
4067 ENSG00000254087 LYN P07948
2342 ENSG00000257365 FNTB P49356

Regulon Drugs

NameApproved SymbolTypeAction TypeMechanism of ActionMax Trial PhaseMax GBM Phase
RUXOLITINIBJAK1Small moleculeINHIBITORTyrosine-protein kinase JAK2 inhibitor41
PACRITINIBFLT3Small moleculeINHIBITORTyrosine-protein kinase receptor FLT3 inhibitor30
LONAFARNIBFNTASmall moleculeINHIBITORProtein farnesyltransferase inhibitor41
IZENCITINIBJAK1Small moleculeINHIBITORJanus Kinase (JAK) inhibitor20
TOFACITINIBJAK1Small moleculeINHIBITORJanus Kinase (JAK) inhibitor40
GANDOTINIBJAK2Small moleculeINHIBITORTyrosine-protein kinase JAK2 inhibitor20
DASATINIBABL1Small moleculeINHIBITORPlatelet-derived growth factor receptor beta inhibitor42
RUXOLITINIB PHOSPHATEJAK1Small moleculeINHIBITORTyrosine-protein kinase JAK2 inhibitor40
PEFICITINIBJAK1Small moleculeINHIBITORJanus Kinase (JAK) inhibitor30
TIPIFARNIBFNTASmall moleculeINHIBITORProtein farnesyltransferase inhibitor32
LESTAURTINIBJAK2Small moleculeINHIBITORTyrosine-protein kinase JAK2 inhibitor30
AC-430JAK2Small moleculeINHIBITORTyrosine-protein kinase JAK2 inhibitor10
BOSUTINIBABL1Small moleculeINHIBITORBcr/Abl fusion protein42
BAFETINIBLYNSmall moleculeINHIBITORTyrosine-protein kinase ABL inhibitor20
MOMELOTINIBJAK1Small moleculeINHIBITORTyrosine-protein kinase JAK2 inhibitor30
NS-018JAK2Small moleculeINHIBITORTyrosine-protein kinase JAK2 inhibitor20
BARICITINIBJAK1Small moleculeINHIBITORTyrosine-protein kinase JAK2 inhibitor40
ILORASERTIBPDGFRBSmall moleculeINHIBITORSerine/threonine-protein kinase Aurora inhibitor20
BMS-911543JAK2Small moleculeINHIBITORTyrosine-protein kinase JAK2 inhibitor20
JNJ-26483327ERBB2Small moleculeINHIBITORTyrosine-protein kinase FYN inhibitor10
UPADACITINIBJAK1Small moleculeINHIBITORJanus Kinase (JAK) inhibitor40
FEDRATINIB HYDROCHLORIDEJAK2Small moleculeINHIBITORTyrosine-protein kinase JAK2 inhibitor40
XL-228ABL1Small moleculeINHIBITORTyrosine-protein kinase ABL inhibitor10
ZOTIRACICLIBCDK9Small moleculeINHIBITORCyclin-dependent kinase 9 inhibitor11
TOFACITINIB CITRATEJAK1Small moleculeINHIBITORJanus Kinase (JAK) inhibitor40
GUSACITINIBSYKSmall moleculeINHIBITORJanus Kinase (JAK) inhibitor20
TOLIMIDONELYNSmall moleculePOSITIVE ALLOSTERIC MODULATORTyrosine-protein kinase Lyn positive allosteric modulator20
TG100-801EPHB4Small moleculeINHIBITORSRC inhibitor20
XL-019JAK2Small moleculeINHIBITORTyrosine-protein kinase JAK2 inhibitor10
AZD-1480JAK2Small moleculeINHIBITORTyrosine-protein kinase JAK2 inhibitor20
DELGOCITINIBJAK1Small moleculeINHIBITORJanus Kinase (JAK) inhibitor30
AT-9283AURKBSmall moleculeINHIBITORTyrosine-protein kinase JAK3 inhibitor20
FEDRATINIBJAK2Small moleculeINHIBITORTyrosine-protein kinase JAK2 inhibitor40
ENMD-981693PDGFRBSmall moleculeINHIBITORPlatelet-derived growth factor receptor inhibitor20

Causal Flows

Causal Flows are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators and regulons. In the causal flow a mutation may causally activates or deactivates a downstream regulator which then might up- or down-regulates a regulon that contains genes with similar expression profiles and binding sites.

Causal Mechanistic Flows for Regulon R-2099

IDMutationRoleRegulatorRoleRegulon# downstream regulons# diffexp regulonsDrugs